Abstract
Clinical studies of cefuzonam (CZON, L-105) were performed in patients of obstetrics and gynecology, and the results obtained are summarized below.
1. CZON was intravenously administered at a daily dose of 1 g to 11 cases including 3cases with intrauterine infection (pyometra), 2 cases of intrapelvic infection (1 case of pelvic dead space infection and 1 case of pelvic peritonitis), 1 case of adnexitis, and others (2 cases of vaginal cuff infection, and 1 case each of vaginal abscess, BALTHOLIN'S abscess, and vulvar abscess).
Clinical efficacy was excellent in 1 case and good in 10 cases.
2. CZON showed a good antibacterial effect in single and mixed infections.
3. Neither side effects nor abnormal values in clinical laboratory findings attributable to the drug were observed.
